BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo H, Ma C, Zheng W, Luo Y, Li C, Li X, Ma X, Feng C, Zhang T, Han Y, Luo Z, Zhan Y, Li R, Wang L, Jiang J. Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters. Adv Funct Mater 2019;29:1808197. [DOI: 10.1002/adfm.201808197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Sabourian P, Tavakolian M, Yazdani H, Frounchi M, van de Ven TG, Maysinger D, Kakkar A. Stimuli-responsive chitosan as an advantageous platform for efficient delivery of bioactive agents. Journal of Controlled Release 2020;317:216-31. [DOI: 10.1016/j.jconrel.2019.11.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 15.5] [Reference Citation Analysis]
2 Pu X, Ye N, Lin M, Chen Q, Dong L, Xu H, Luo R, Han X, Qi S, Nie W, He H, Wang Y, Dai L, Lin D, Gao F. β-1,3-d-Glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment. Carbohydr Polym 2021;273:118612. [PMID: 34561010 DOI: 10.1016/j.carbpol.2021.118612] [Reference Citation Analysis]
3 Song M, Zhang S, Tao Z, Li J, Shi Y, Xiong Y, Zhang W, Liu C, Chen S. MMP-12 siRNA improves the homeostasis of the small intestine and metabolic dysfunction in high-fat diet feeding-induced obese mice. Biomaterials 2021;278:121183. [PMID: 34653936 DOI: 10.1016/j.biomaterials.2021.121183] [Reference Citation Analysis]
4 Ahmed O, Abdel-Halim M, Farid A, Elamir A. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats. Chem Biol Interact 2022;351:109715. [PMID: 34695389 DOI: 10.1016/j.cbi.2021.109715] [Reference Citation Analysis]
5 Cheng L, Shi L, He C, Wang C, Lv Y, Li H, An Y, Dai H, Duan Y, Zhang H, Huang Y, Fu W, Meng Y, Zhao B. Rutin-activated adipose tissue thermogenesis is correlated with increased intestinal short-chain fatty acid levels. Phytother Res 2022. [PMID: 35445769 DOI: 10.1002/ptr.7462] [Reference Citation Analysis]
6 Li F, Zhe T, Ma K, Li R, Li M, Liu Y, Cao Y, Wang L. A Naturally Derived Nanocomposite Film with Photodynamic Antibacterial Activity: New Prospect for Sustainable Food Packaging. ACS Appl Mater Interfaces 2021. [PMID: 34723456 DOI: 10.1021/acsami.1c12243] [Reference Citation Analysis]
7 Xia Y, Wang Y, Xie J, Yu E, Tian J, Li Z, Zhang K, Gong W, Wang G. Effects of BBR on growth performance, serum and hepatic biochemistry parameters, hepatic morphology and gene expression levels related to glucose metabolism in largemouth bass, Micropterus salmoides. Aquaculture Research. [DOI: 10.1111/are.15887] [Reference Citation Analysis]
8 Cheng S, Shen H, Zhao S, Zhang Y, Xu H, Wang L, Di B, Xu L, Hu C. Orally administered mesoporous silica capped with the cucurbit[8]uril complex to combat colitis and improve intestinal homeostasis by targeting the gut microbiota. Nanoscale 2020;12:15348-63. [PMID: 32648873 DOI: 10.1039/d0nr03037f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li XL, Cui JJ, Zheng WS, Zhang JL, Li R, Ma XL, Lin M, Guo HH, Li C, Yu XY, Du P, Zhao LM, He S, Lan P, Jiang JD, Che Y, Wang LL. Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota. Small 2022;:e2105021. [PMID: 35088527 DOI: 10.1002/smll.202105021] [Reference Citation Analysis]
10 Yue SJ, Wang WX, Yu JG, Chen YY, Shi XQ, Yan D, Zhou GS, Zhang L, Wang CY, Duan JA, Tang YP. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach. Pharmacol Res 2019;148:104453. [PMID: 31541688 DOI: 10.1016/j.phrs.2019.104453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
11 Zhang P, Li Y, Tang W, Zhao J, Jing L, Mchugh KJ. Theranostic nanoparticles with disease-specific administration strategies. Nano Today 2022;42:101335. [DOI: 10.1016/j.nantod.2021.101335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tang R, Li R, Li H, Ma XL, Du P, Yu XY, Ren L, Wang LL, Zheng WS. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. ACS Nano 2021. [PMID: 34705426 DOI: 10.1021/acsnano.1c02158] [Reference Citation Analysis]
13 Habtemariam S. Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacol Res. 2020;155:104722. [PMID: 32105754 DOI: 10.1016/j.phrs.2020.104722] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
14 Yang Y, Vong CT, Zeng S, Gao C, Chen Z, Fu C, Wang S, Zou L, Wang A, Wang Y. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies. J Ethnopharmacol 2021;268:113573. [PMID: 33181286 DOI: 10.1016/j.jep.2020.113573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wu A, Chen C, Lu J, Sun J, Xiao M, Yue X, Zhou P, Zhao S, Zhong G, Huang C, Qu Y, Zhang C. Preparation of Oral Core-Shell Zein Nanoparticles to Improve the Bioavailability of Glycyrrhizic Acid for the Treatment of Ulcerative Colitis. Biomacromolecules 2021. [PMID: 34905341 DOI: 10.1021/acs.biomac.1c01233] [Reference Citation Analysis]
16 Hu M, Huang L. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Adv Drug Deliv Rev 2022;:114137. [PMID: 35143893 DOI: 10.1016/j.addr.2022.114137] [Reference Citation Analysis]
17 Qiao L, Han M, Gao S, Shao X, Wang X, Sun L, Fu X, Wei Q. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B 2020;8:6333-51. [PMID: 32633311 DOI: 10.1039/d0tb01260b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]